Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.

Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V.

Int J Mol Sci. 2019 Mar 19;20(6). pii: E1381. doi: 10.3390/ijms20061381. Review.

2.

Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer.

De Amicis F, Chimento A, Montalto FI, Casaburi I, Sirianni R, Pezzi V.

Int J Mol Sci. 2019 Mar 3;20(5). pii: E1087. doi: 10.3390/ijms20051087. Review.

3.

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.

Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, Pezzi V, Sirianni R.

Front Endocrinol (Lausanne). 2019 Jan 21;9:807. doi: 10.3389/fendo.2018.00807. eCollection 2018. Review.

4.

Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines.

Mancuso R, Ziccarelli I, Chimento A, Marino N, Della Ca' N, Sirianni R, Pezzi V, Gabriele B.

iScience. 2018 May 25;3:279-288. doi: 10.1016/j.isci.2018.04.022. Epub 2018 May 3.

5.

Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment.

Casaburi I, Chimento A, De Luca A, Nocito M, Sculco S, Avena P, Trotta F, Rago V, Sirianni R, Pezzi V.

Front Endocrinol (Lausanne). 2018 Sep 11;9:525. doi: 10.3389/fendo.2018.00525. eCollection 2018. Review.

6.

Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions.

Parisi OI, Scrivano L, Amone F, Malivindi R, Ruffo M, Vattimo AF, Pezzi V, Puoci F.

J Funct Biomater. 2018 Jul 12;9(3). pii: E44. doi: 10.3390/jfb9030044.

7.

GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.

Casaburi I, Avena P, De Luca A, Sirianni R, Rago V, Chimento A, Trotta F, Campana C, Rainey WE, Pezzi V.

Oncotarget. 2017 Dec 14;8(70):115609-115619. doi: 10.18632/oncotarget.23314. eCollection 2017 Dec 29.

8.

Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.

De Luca A, Avena P, Sirianni R, Chimento A, Fallo F, Pilon C, Casaburi I, Pezzi V.

Cells. 2017 Nov 7;6(4). pii: E42. doi: 10.3390/cells6040042.

9.

Calabrian Goji vs. Chinese Goji: A Comparative Study on Biological Properties.

Ruffo M, Parisi OI, Amone F, Malivindi R, Gorgoglione D, De Biasio F, Scrivano L, Pezzi V, Puoci F.

Foods. 2017 Apr 10;6(4). pii: E30. doi: 10.3390/foods6040030.

10.

Determination of mercury in hair: Comparison between gold amalgamation-atomic absorption spectrometry and mass spectrometry.

Domanico F, Forte G, Majorani C, Senofonte O, Petrucci F, Pezzi V, Alimonti A.

J Trace Elem Med Biol. 2017 Sep;43:3-8. doi: 10.1016/j.jtemb.2016.09.008. Epub 2016 Sep 29.

PMID:
27769745
11.

Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment.

Chimento A, Sirianni R, Saturnino C, Caruso A, Sinicropi MS, Pezzi V.

Mini Rev Med Chem. 2016;16(9):699-709. Review.

PMID:
26996623
12.

Development of a novel cell based androgen screening model.

Campana C, Rege J, Turcu AF, Pezzi V, Gomez-Sanchez CE, Robins DM, Rainey WE.

J Steroid Biochem Mol Biol. 2016 Feb;156:17-22. doi: 10.1016/j.jsbmb.2015.11.005. Epub 2015 Nov 12.

13.

Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.

Chimento A, Saturnino C, Iacopetta D, Mazzotta R, Caruso A, Plutino MR, Mariconda A, Ramunno A, Sinicropi MS, Pezzi V, Longo P.

Bioorg Med Chem. 2015 Nov 15;23(22):7302-12. doi: 10.1016/j.bmc.2015.10.030. Epub 2015 Oct 24. Erratum in: Bioorg Med Chem. 2015 Dec 15;23(24):7785.

PMID:
26526741
14.

Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).

Casaburi I, Avena P, De Luca A, Chimento A, Sirianni R, Malivindi R, Rago V, Fiorillo M, Domanico F, Campana C, Cappello AR, Sotgia F, Lisanti MP, Pezzi V.

Oncotarget. 2015 Sep 22;6(28):25135-48. doi: 10.18632/oncotarget.4722.

15.

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

Chimento A, Sirianni R, Casaburi I, Zolea F, Rizza P, Avena P, Malivindi R, De Luca A, Campana C, Martire E, Domanico F, Fallo F, Carpinelli G, Cerquetti L, Amendola D, Stigliano A, Pezzi V.

Oncotarget. 2015 Aug 7;6(22):19190-203.

16.

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.

De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F.

Oncotarget. 2015 Jun 20;6(17):14777-95.

17.

Cell-based assays for screening androgen receptor ligands.

Campana C, Pezzi V, Rainey WE.

Semin Reprod Med. 2015 May;33(3):225-34. doi: 10.1055/s-0035-1552989. Epub 2015 Jun 2. Review.

18.

C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines.

Cerquetti L, Sampaoli C, De Salvo M, Bucci B, Argese N, Chimento A, Vottari S, Marchese R, Pezzi V, Toscano V, Stigliano A.

Int J Oncol. 2015 May;46(5):2231-40. doi: 10.3892/ijo.2015.2902. Epub 2015 Feb 24.

PMID:
25708932
19.

Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts.

Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, Dolce V, Abonante S, Pezzi V, Maggiolini M.

Environ Health Perspect. 2015 May;123(5):493-9. doi: 10.1289/ehp.1408586. Epub 2015 Jan 16.

20.

GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts.

De Marco P, Romeo E, Vivacqua A, Malaguarnera R, Abonante S, Romeo F, Pezzi V, Belfiore A, Maggiolini M.

Endocr Relat Cancer. 2014 Oct;21(5):739-53. doi: 10.1530/ERC-14-0245. Epub 2014 Jul 10.

PMID:
25012984

Supplemental Content

Loading ...
Support Center